Analysts: Discovery Sales Will Increase and 2 Other Research Notes to Check Out

Discovery (NASDAQ:DSCA): Follwing lower than expected Q1 EPS, RBC Capital finds that the company’s ad sales should pick up, albeit modestly, in the second half of 2013. It also maintains that┬áthe company’s strategy of investing in international platforms will sustain growth over the long-term, and rates the shares at Outperform.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

DISCA

MAKO Surgical (NASDAQ:MAKO): Shares of MAKO were priced for a larger miss, according to Piper Jaffray, which believes the 47 percent year-over-year growth in implants backs the stabilizing utilization trends. Piper continues to see MAKO shares Outperform over the next year, and it reiterates an Overweight rating with a $23 price target.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

MAKO

Baxter (NYSE:BAX): Bernstein believes that investors were expecting the news that Baxter would miss its Alzheimer’s study end points, and noted that the company has several upcoming catalysts.┬áThe firm thinks that the stock’s valuation is compelling based on a sum of the parts analysis, and it reiterates an Outperform rating on the shares.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

BAX

Don’t Miss: Will Apple Lose the Profit Crown to Samsung?